Cargando...

Immunocompatibility of a new dual modality contrast agent based on radiolabeled iron-oxide nanoparticles

Radiolabeled magnetic nanoparticles are promising candidates as dual-modality-contrast-agents (DMCA) for diagnostic applications. The immunocompatibility of a new DMCA is a prerequisite for subsequent in vivo applications. Here, a new DMCA, namely Fe(3)O(4) nanoparticles radiolabeled with (68)Ga, is...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Sci Rep
Main Authors: Karageorgou, Maria-Argyro, Stamopoulos, Dimosthenis
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2021
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8105398/
https://ncbi.nlm.nih.gov/pubmed/33963211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-89117-3
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!